PTC Therapeutics (PTCT) Proxy filing summary

Voting matters and shareholder proposals

• Four Class I directors nominated for election: Jessica Chutter, Matthew B. Klein, Stephanie S. Okey, and Jerome B. Zeldis.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on named executive officer compensation (say-on-pay) included.

• Provision to transact other business as may be properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.

Executive compensation and say-on-pay

• Advisory vote solicited on executive compensation as described in the proxy statement.